RG1068 (Synthetic Human Secretin)

Phase 3Terminated
0 watching 0 views this week๐Ÿ“ˆ Rising
74
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Autism

Conditions

Autism

Trial Timeline

Apr 1, 2002 โ†’ โ€”

About RG1068 (Synthetic Human Secretin)

RG1068 (Synthetic Human Secretin) is a phase 3 stage product being developed by Repligen for Autism. The current trial status is terminated. This product is registered under clinical trial identifier NCT00036231. Target conditions include Autism.

Hype Score Breakdown

Clinical
27
Activity
18
Company
7
Novelty
9
Community
10

Clinical Trials (4)

NCT IDPhaseStatus
NCT00660335Phase 3Completed
NCT00216294Phase 2Completed
NCT00036231Phase 3Terminated
NCT00036244Phase 3Completed

Competing Products

20 competing products in Autism

See all competitors